News Snapshot:
A Sinovac production line for the coronavirus vaccine at its Beijing site. (Photo by Shin Watanabe) SHIN WATANABE, Nikkei staff writer, and NORIYUKI TAKADA, Nikkei advanced medicine editor November 27, 2020 03:29 JST | China Copy Copied BEIJING -- China's vaccine diplomacy faces a setback as questions arise about the efficacy and safety of its coronavirus inoculations while the country speeds a large-scale rollout despite the candidates remaining in the clinical trial phase. Beijing once led the global race to develop a COVID-19 vaccine, but U.S. and European pharmaceutical firms are close to bringing candidates to market. On Nov. 17,...
